Latest Administration News

Acumentis Group Limited has reported a robust FY2025 with a 35% jump in operating profits and declared a fully franked dividend, signaling confidence in its growth trajectory.

NRW Holdings reported a robust 12.2% revenue increase to $3.3 billion in FY25, offsetting a significant $110.5 million impairment linked to OneSteel. Strong Civil and MET segment growth underpinned solid earnings despite Queensland weather challenges.

NRW Holdings reported a 12.2% revenue increase to $3.27 billion in FY25, offset by a significant impairment linked to OneSteel receivables. The company declared a final fully franked dividend of 9.5 cents per share, underscoring confidence despite challenges.

Netwealth Group Limited reported robust FY25 results, with Funds Under Administration soaring to $112.8 billion and net profit after tax climbing nearly 40%, underpinned by strong operational leverage and strategic investments.

Netwealth Group Limited has reported a stellar FY25 with record funds under administration net flows of $15.8 billion and a 31% rise in EBITDA, underpinned by strong adviser growth and strategic technology investments.

EQT Holdings Limited reported record funds under management and a solid financial performance for FY25, successfully completing its three-year strategic integration program. The company’s margin recovery and dividend growth signal a confident outlook amid ongoing regulatory challenges.

Equity Trustees reports record funds under management of $254 billion and a 60% jump in statutory net profit, completing a transformative three-year strategic agenda.

Netwealth Group Limited reported a standout FY2025 with net profit rising nearly 40% and funds under administration climbing 28%, underpinning a 37.5% increase in dividends. Strategic fintech acquisitions and robust governance enhancements position the company for sustained growth.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.

IPH Limited reported a solid 16.5% revenue increase to $710.3 million for FY25, driven by strategic acquisitions in Canada and strong organic growth in Asia and ANZ. Despite ongoing delays at the Canadian Intellectual Property Office, the company achieved higher earnings and dividends, setting the stage for further operational efficiencies and technology investments.

IPH Limited reported a robust FY25 with revenue rising 16.6% to $710.3 million and net profit after tax up 13.2% to $68.8 million, driven by strategic acquisitions and a pivot towards organic growth and AI integration.

Insignia Financial has reported a robust FY25 with a 17.6% rise in underlying net profit after tax and a record $330.3 billion in funds under management. The company also unveiled its ambitious strategy to become Australia's leading diversified wealth manager by 2030.